Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shanghai Jia Fu Medical Apparatus Starts Stem Cell Clinical Trial

publication date: Jul 17, 2012
Shanghai Jia Fu Medical Apparatus Inc. has completed the dosing of two patients with an experimental stem cell treatment developed by MediStem of the US. Endometrial Regenerative Cell (ERC) is a universal donor stem cell product collected from the uterus. It was administered as an intramuscular injection to two patients with critical limb ischemia as part of a 15-patient study. Neither patient showed any signs of adverse effects. More details....

Stock Symbol: (PinkSheets: MEDS)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital